Xavier Legras
Impact in
- Immunology top 10%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- CRISPR and Genetic Engineering 4
- Pluripotent Stem Cells Research 1
- Mitochondrial Function and Pathology 1
- Cell death mechanisms and regulation 1
-
- Hepatitis B Virus Studies 4
- Co-authors
- Helen Y. Wang (2 shared papers)Xiaojun Xia (1 shared paper)Shu Zheng (1 shared paper)Jun Ki Hong (1 shared paper)Liang Zhu (1 shared paper)Zhijian J. Chen (1 shared paper)Jun Cui (1 shared paper)Rong‐Fu Wang (1 shared paper)
- Journals
- Nature Communications (3 papers)JHEP Reports (3 papers)PLoS ONE (2 papers)Molecular Therapy — Methods & Clinical Development (1 paper)Cell (1 paper)
- Partner nations
- United StatesPolandChina
In The Last Decade
Xavier Legras
14 papers receiving 738 citations
Peers
Comparison fields: 5 of 82
- Immunology 304
- Business and International Management 19
- Aging 16
- Hepatology 54
- Molecular Biology 393
Countries citing papers authored by Xavier Legras
This map shows the geographic impact of Xavier Legras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Legras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Legras more than expected).
Fields of papers citing papers by Xavier Legras
This network shows the impact of papers produced by Xavier Legras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Legras. The network helps show where Xavier Legras may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier Legras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 365 | |
| 2 | 2016 | 103 | |
| 3 | 2018 | 67 | |
| 4 | 2015 | 45 | |
| 5 | 2021 | 35 | |
| 6 | 2017 | 30 | |
| 7 | 2006 | 20 | |
| 8 | 2017 | 18 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 15 | |
| 11 | 2012 | 13 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 6 | |
| 14 | 2025 | 2 |
About Xavier Legras
Xavier Legras is a scholar working on Molecular Biology, Epidemiology, Immunology, Surgery and Ecology, having authored 14 papers that have together received 744 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (4 papers), CRISPR and Genetic Engineering (4 papers), Pharmacogenetics and Drug Metabolism (1 paper), Bacteriophages and microbial interactions (1 paper), Immunotherapy and Immune Responses (1 paper), Pluripotent Stem Cells Research (1 paper), Mitochondrial Function and Pathology (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Immunology (304 citations), Business and International Management (19 citations), Aging (16 citations), Hepatology (54 citations) and Molecular Biology (393 citations). Xavier Legras has collaborated with scholars based in United States, Poland and China. Frequent co-authors include Helen Y. Wang, Xiaojun Xia, Shu Zheng, Jun Ki Hong, Liang Zhu, Zhijian J. Chen, Jun Cui, Rong‐Fu Wang, Pingping Shen and Jiabing Ji. Their work appears in journals such as Nature Communications, JHEP Reports, PLoS ONE, Molecular Therapy — Methods & Clinical Development and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.